Steatotic Liver Disease: Completing the Care Mosaic—From Missed Diagnosis to Better Outcomes

Steatotic liver disease represents a substantial clinical and public health burden. This program will examine the role of non-invasive tests in the identification and referral of patients, explore approaches to enhancing early intervention and review the evidence supporting fibrosis regression as a key objective to improve patient outcomes.

Industry Supporter: GSK